Background Several cardiac surgery risk prediction models based on postoperative data have been developed. However, unlike preoperative cardiac surgery risk prediction models, postoperative models are rarely externally validated or utilized by clinicians. The objective of this study was to externally validate three postoperative risk prediction models for intensive care unit (ICU) mortality after cardiac surgery. Methods The logistic Cardiac Surgery Scores (logCASUS), Rapid Clinical Evaluation (RACE), and Sequential Organ Failure Assessment (SOFA) scores were calculated over the first 7 postoperative days for consecutive adult cardiac surgery patients between January 2013 and May 2015. Model discrimination was assessed using receiver operating characteristic curve analyses. Calibration was assessed using the HosmerLemeshow (HL) test, calibration plots, and observed to expected ratios. Recalibration of the models was performed. Results A total of 2255 patients were included with an ICU mortality rate of 1.8%. Discrimination for all three models on each postoperative day was good with areas under the receiver operating characteristic curve of >0.8. Generally, RACE and logCASUS had better discrimination than SOFA. Calibration of the RACE score was better than logCASUS, but ratios of observed to expected mortality for both were generally <0.65. Locally recalibrated SOFA, logCASUS and RACE models all performed well. Conclusion All three models demonstrated good discrimination for the first 7 days after cardiac surgery. After recalibration, logCASUS and RACE scores appear to be most useful for daily risk prediction after cardiac surgery. If appropriately calibrated, postoperative cardiac surgery risk prediction models have the potential to be useful tools after cardiac surgery.
Introduction
Preoperative cardiac surgery risk prediction models, such as the EuroSCORE models, [1] [2] [3] have been widely adopted and extensively studied. The primary purpose of such models is to allow the risk of mortality to be estimated prior to intervention. The risk estimates can be used to inform clinical decision making when considering intervention and to riskadjust surgical outcome data on an 'intention to treat' basis. However, once an intervention has taken place preoperative models become less useful because intraoperative and postoperative events that may affect risk are not taken into account. Following intervention, models which include risk factors from the intra-and postoperative periods may be more useful for estimating risk and could aid postoperative clinical decision making and allow benchmarking of cardiac intensive care unit (CICU) performance.
Several potentially useful models which analyze postoperative data have been developed. Some models designed for use in general intensive care unit (ICU) patients also accurately predict mortality after cardiac surgery, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] with the Sequential
Organ Failure Assessment (SOFA) score generally demonstrating the best performance. 7, 15 The Cardiac Surgery Risk Score (CASUS) and its derivatives are examples of models designed specifically for use following cardiac surgery. The CASUS model has been validated in Germany using data from multiple institutions 4, 6, 11, 12, 16 and in a study of 150 patients in Greece.
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The derivative Logistic Cardiac Surgery Risk Score (logCASUS) 18 and Rapid Clinical Evaluation (RACE) 19 models which calculate ICU mortality risk have not been externally validated. Despite several models being available, few are utilized in clinical practice. This lack of adoption may be due to the absence of comparative external validation studies in contemporary cohorts. The objective of this study was therefore to validate the logCASUS, RACE, and SOFA scores for the prediction of ICU mortality in cardiac surgery patients. The performance of serial daily scores for each model was also assessed.
Patients and Methods
Prospectively collected data for consecutive adult patients admitted to the CICU at our institution following cardiac surgery between January 1, 2013 and May 31, 2015 were analyzed. Our institution is a tertiary adult cardiac surgery center, and our case-mix includes patients undergoing cardiac transplantation and mechanical circulatory support. As in the original studies which described the logCASUS 18 and RACE 19 scores, only data from each patient's first CICU admission after cardiac surgery were included. Patients whose CICU admissions were too short to allow calculation of risk using the models were excluded. The primary outcome for the study was ICU mortality.
Data Collection, Validation, and Cleaning
Preoperative patient characteristics and postoperative outcome data were collected from the clinical governance database, which is compiled by clinicians and validated by database managers. Postoperative data from the patients' CICU admissions were obtained from the electronic patient record. Results of blood analyses were obtained from the pathology laboratory database, and data concerning postoperative cerebrovascular accidents were obtained from the radiology database. As described in the original studies, 15, 18, 19 the most abnormal value for each variable recorded each day was entered into the models. Data from all four sources were collated and cleaned using reproducible algorithms in R Studio (R Foundation for Statistical Computing).
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All data were entered into the Vascular Governance North West database and were managed according to the protocol and ethical approvals governing this database. As data were pseudonymized prior to analysis, the Research Ethics Committee concluded that ethical approval for these analyses was not necessary.
Missing Data
Where a variable was not measured on a given day, the patient's most recent postoperative value was used to calculate the risk score. Except for bilirubin, substituted blood test data were required in <3% of risk score calculations. Previous postoperative bilirubin concentrations were not available for 8.3% of daily calculations, and therefore, missing values were substituted using the nearest subsequent value for that patient. Where the above-mentioned substitutions were not possible due to a complete absence of data for a given patient, the median value for that parameter in all patients was imputed. Bilirubin was imputed in this way for 6.2% of patients, but other variables were only imputed for 0.1% of patients.
For the logCASUS score, calculation of the pressure-adjusted heart rate (PAR) (which combines information from heart rate, central venous pressure [CVP] , and mean arterial pressure) was not possible for 7% of score calculations. This was most commonly because the central venous catheter had been removed before CICU discharge. To address missing CVP data, a logistic regression model was developed using data from patients for whom data was complete. This model was then used to calculate a modeled PAR. There were no missing outcome data.
Statistical Analyses
Central tendency of variables is described using mean and standard deviation where the distribution was parametric, and median and interquartile range where the distribution was non-parametric.
The logCASUS, RACE, and SOFA scores were calculated for each patient on a daily basis for postoperative days 1 to 7. The discrimination of all scores for the prediction of ICU mortality was assessed using the area under the receiver operating characteristic curve (AUC). DeLong et al's method for calculating AUC variance was used for the calculation of AUC 95% confidence intervals (CI).
21 AUC values of !0.7 were considered acceptable and values !0.8 were considered good. The calibration of logCASUS and RACE ICU mortality risk estimates was assessed using the ratio of observed outcomes to predicted outcomes (O:E ratio), the Hosmer risk and observed outcomes. 22 The calibration plots illustrate how the mean predicted probability of ICU mortality compares with the observed incidence of ICU mortality for five equally sized groups based on the ranked predicted risks calculated by the model. Calibration of the original SOFA score could not be evaluated because it is a non-logistic score.
A sub-group analysis excluding patients who underwent cardiac transplantation or initiation of mechanical circulatory support was also performed. Finally, local recalibration of the models was performed. Data were divided randomly into two equally sized datasets; a training dataset and an evaluation dataset. Each model was fully recalibrated using data for each variable from the training dataset. The calibration and discrimination of each recalibrated model was then tested in the evaluation dataset.
Results

Patient Characteristics
There were 2,284 consecutive patients who met the inclusion criteria. Twenty-nine patients were excluded because their admission to CICU was too short to allow calculation of the risk scores. The mean (standard deviation [SD]) age of the patients was 65.8 (11.8), and 27.3% were female. The most common procedure was isolated coronary artery bypass graft surgery (53.3%). Additional patient and operative characteristics are shown in ►Table 1. The overall ICU mortality rate was 2.0%. The ICU mortality rate in the final validation cohort was 1.8%.
Model Performance on the First Postoperative Day
The variables included in each model are detailed in ►Table 2. A day-by-day description of the levels of risk predicted by the models is shown in ►Appendix A. All three models demonstrated good discrimination when calculated on the first postoperative day (►Fig. 1A). The AUC for the RACE and logCASUS scores were the same at 0.94 (95%CI 0.91-0.97) for both. The AUC for the SOFA score was 0.91 (95%CI 0.86-0.96). The HL tests, together with the comparison of the O:E ratios and calibration plots implied poor calibration of both logistic models (►Table 3). As seen in ►Fig. 1B, predictions were least accurate for those patients who had the highest predicted risk. Sub-group analysis demonstrated no significant effect on model performance when patients undergoing cardiac transplantation or initiation of mechanical circulatory support were excluded. Cardiac Surgery Risk Prediction Models for ICU Mortality Howitt et al. 653
Serial Scores
The daily measures of discrimination and calibration for the models are shown in ►Table 3. LogCASUS and RACE scores calculated daily up to day 7 of the postoperative CICU admission demonstrated good discrimination. The AUC of the SOFA score was generally lower than those of the cardiac surgery-specific scores in the early postoperative period, but the difference reduced toward the end of the first postoperative week. Calibration plots, HL test, and O:E ratios suggested poor calibration for logCASUS. Calibration for RACE was better, but remained suboptimal.
Local Recalibration
The AUC, O:E ratios, and HL test results for the recalibrated models' performance in the evaluation dataset are detailed in ►Table 4. The analyses of recalibrated model performance were limited to the first 5 days as the training dataset only contained seven patients who died after being in CICU for >5 days. Local recalibration of models using the training dataset generally resulted in marginal improvement in discrimination for all scores. The calibration of the recalibrated logCASUS model was adequate on every day. The HL tests for RACE and SOFA suggested adequate calibration on every day 
Discussion
This study has validated the performance of the logCASUS, RACE, and SOFA scores in a cohort of 2,255 patients from a tertiary cardiac center in the United Kingdom. The observed ICU mortality (1.8%) is in line with that for all cardiac surgery in the United Kingdom. 23 This is despite the cohort including 62 patients who underwent emergency/salvage procedures and 41 who underwent instigation of mechanical circulatory support. In these groups, ICU mortality was 21.0% and 24.3%, respectively. In the remaining patients, the ICU mortality rate was 1.2%. All models demonstrated good discrimination throughout the first postoperative week with discrimination declining slightly toward the end of the week. Both the logCASUS and RACE scores demonstrated poor calibration in our cohort and significantly over-predicted risk. The poor calibration demonstrated by the RACE and CASUS models may be due to a similar calibration drift effect to that observed with preoperative risk models due to improvements in care and clinical outcomes over time. 24 Assuming that our findings of poor calibration of the original models are replicated elsewhere, the models would need to be recalibrated before the risk estimates could be clinically useful. 25 After recalibration in our training cohort, all models demonstrated improved calibration using the HL test but underpredicted risk in lower risk groups and overpredicted risk in higher risk group. Overall, the logCASUS was slightly better calibrated than SOFA and RACE. This study represents the first external validation of the logCASUS and RACE models and the first validation of the SOFA score in United Kingdom cardiac surgery. We utilized contemporary data from a tertiary cardiac center with excellent clinical results and undertook a comprehensive assessment of model performance. As with any clinical study, there were missing data, but the proportion in this study was low. The variables with the most missing data were PAR (required for logCASUS calculation only) and serum bilirubin. A clinically robust approach for handling missing data was adopted.
A potential limitation of the study is that it is based on data from a single center and includes relatively few outcomes. The division of our dataset for development and evaluation of locally recalibrated versions of the models exacerbated this problem, and so, we limited the evaluation of the recalibrated models to the first 5 postoperative days. When the number of outcomes is low, validation results and performance statistics need to be interpreted with caution. Potential options to increase the sample size would be to expand the number of participating centers or increase the timeframe for data collection. The first option is not feasible at present due to a lack of United Kingdom centers currently collecting the necessary data in a suitable format. Although the second option is feasible, this would introduce temporal issues related to changes in practice and performance over time that could affect the results. Cardiac Surgery Risk Prediction Models for ICU Mortality Howitt et al. 655
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The SOFA score was the first of the validated models to be developed and was designed based on expert consensus in 1996 to assess the progress of patients suffering from sepsis. 15 It has since been validated as a prediction tool for adverse outcomes in general ICU patients 26 and also specifically in patients who have undergone cardiac surgery. 7, 10 It grades the function of six organ systems using a five-point scale for each with totals ranging between 0 and 24 (►Table 2; ►Appendix D).
The logistic logCASUS 18 and RACE 19 scores were developed by the same team as the additive CASUS score 4 using data from a single center. The RACE score was designed as a user friendly version of logCASUS. Unlike SOFA, these scores were developed exclusively for patients who have undergone cardiac surgery. They both include use of mechanical circulatory support and intra-aortic balloon pump counterpulsation, which are more common in cardiac surgery patients than in the general ICU population. Both scores grade neurological status using a scale which reduces the impact of the low conscious level expected immediately after cardiac surgery and adjust the predicted risk based on the time since surgery (►Appendices B and C).
During the recalibration process, we were able to identify which variables within each model were significantly associated with ICU mortality. We found that variables which can be controlled by physicians, such as MAP and PAR, were not significantly associated with outcome. Conversely, interventions which may affect those parameters such as use of mechanical ventilation, renal replacement therapy, or mechanical circulatory support were shown to have significant and relatively large effects on risk. Serum creatinine and lactate concentrations and the platelet count were the most significant of the blood analyses assessed (►Appendices B-D).
Despite generally superior discriminatory ability compared with preoperative models, 27 none of the validated models has been widely adopted in clinical practice. Possible reasons for this include problems with the ability to easily calculate the scores, a perceived lack of clinical utility or validity, and inadequate external validation studies. Clinical utility of the scores is limited by the fact that they are inherently retrospective as they rely on the worst value obtained over a 24-hour period. Importantly, the cardiac surgery-specific scores are designed to be used only during a patient's first admission to CICU. In addition, in these models the first postoperative day is the reference for the "ICU day" variable, that is, the β-coefficient for postoperative day 1 is zero. The models do not provide an "ICU day" coefficient for the operative day and consequently cannot produce risk estimates until the first postoperative day. As a result of these limitations in model design, the logCASUS and RACE risk scores could not be calculated for 29 patients for whom the first ICU episode finished on the operative day. This is clinically relevant because for 24 of these patients, the short initial admission was due to reoperation for bleeding, and the ICU mortality rate in this group was 17%. Although this did not significantly change the overall ICU mortality rate (2.0% versus 1.8%), the inability to assess risk in these patients is a limitation of the models. Despite limitations, the models studied could potentially be utilized for three main purposes. All models discriminate well between patients at high and low risk of mortality; therefore, clinicians could use the scores to identify patients with the highest risk among those present on CICU and to target resources including staff allocations accordingly. Second, if validated in multicenter studies, the models could be utilized for the risk-adjustment of CICU benchmarking data in a similar way to that in which preoperative models have been used to risk-adjust surgical outcome data. 28 Utilizing models that include postoperative variables to generate risk predictions allows risk estimates to be modified by the occurrence of intra-and early postoperative events. Such estimates would be better suited for the assessment of CICU performance. If the models were to be used for this purpose, risk predictions should be made early in the CICU stay because scores calculated later are likely to be influenced by the quality of care already received in the CICU. Lastly, if the models are appropriately calibrated, daily scores could be used to assess patient progress, assist clinical decision making, and to inform discussions with patients and their relatives by providing the most up-to-date assessment of patient risk possible. Although predictions will never be completely accurate for individual patients, they may be used as a guide.
In conclusion, all three models showed good discrimination when used during the first postoperative week after cardiac surgery. In their original forms, the cardiac surgery-specific models were poorly calibrated, particularly in patients with the highest risk, but all three models could be recalibrated using local data. Further research into optimizing postoperative models to maximize their clinical utility is required if they are going to be widely adopted.
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Appendix A The proportion of patients with low, medium, and high predicted ICU mortality risk on each day during the first postoperative week Abbreviations: IABP, Intra-aortic balloon pump; CI, confidence interval; MAP, mean arterial pressure; VA ECMO, venoarterial extracorporeal membrane oxygenation; VAD, ventricular assist device.
